Practice Update: Cardiology

First page Previous page 14 Next page Last page

EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 14

Dr Deepak Bhatt picks ASCOT, EMPA-REG OUTCOME, FRISC II and ANNEXA-4 as some of his ESC 2016 top abstracts

ESC 2016 27–31 AUGUST 2016 • ROME, ITALY

This year’s European Society of Cardiology (ESC) Congress saw the presentation of key studies such as the DANISH, PRAGUE-16, CE MARC 2, SAVE and NACIAM trials. PracticeUpdate Cardiology Advisory Board member Dr Deepak Bhatt lists his top abstracts from ESC 2016, while Professor TomMarwick and Professor Garry Jennings share their insights from the meeting.

Deepak Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School.

Clinical trial update: prevention The influence of blinding and un-blinding on statin related adverse events: new evidence from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Presented by A Gupta Clinical trial update: heart failure and pacing Effects of empagliflozin on cardiovascular mortality by prevalent or incident heart failure in EMPA-REG OUTCOME. Presented by D Fitchett Effects of empagliflozin on overall heart failure burden in EMPA-REG OUTCOME. Presented by D Fitchett

Clinical trial update: coronary artery disease A life-time perspective on the effects of an early invasive compared with a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome – the FRISC II 15 years follow-up. Presented by L Wallentin Hot line: prevention and lipids A naturally randomised trial comparing the effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular disease. Presented by BA Ference Hot line: coronary artery disease and imaging

AMERICA – Systematic detection and management of multivascular involvement of atherothrombosis in coronary patients in comparison with treatment of coronary disease only. Presented by J-P Collet Clinical trial update: platelet therapy Prevention of first stroke with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS- TIMI 54. Presented by M Bonaca Hot line: preventive strategies 2 ANNEXA-4 –Andexanet alfa for reversal of Factor Xa inhibitors in patients with acute major bleeding. Presented by SJ Connolly Registries: miscellaneous Optimal blood pressure in CAD patients: is there a J-curve phenomenon? Insights from 22,695 hypertensive CAD patients in the CLARIFY registry. Presented by PG Steg

Made with FlippingBook